A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

The formula is designed to work for people of all ages and body conditions. Relevant clinical studies and research-based ...

Cannabidiol (CBD) has become a popular supplement for a range of purported health benefits, including anti-inflammatory effects. But does research support the anti-inflammatory claims often touted by ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

The tablet is not entirely safe to consume on a regular basis unless under the supervision of a physician. Side effects ...

Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ...